UVMFLOWNET Archives

December 2010

UVMFLOWNET@LIST.UVM.EDU
Options: Use Monospaced Font
Show Text Part by Default
Show All Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Subject:
Re: "Vascular Age"
From:
Connie McCoy <[log in to unmask]>
Reply To:
UVM Flownet <[log in to unmask]>
Date:
Wed, 1 Dec 2010 09:01:30 -0500
Content-Type:
text/plain
Parts/Attachments:
text/plain (10 lines) 
Let me be clear.
I have no financial stake or self promotion.  Only reporting the facts as reported to me by a lead investigator of the Bogalusa Heart Study.  
CIMT plays a very valuable role in research, CV prevention, risk stratification, and monitoring of risk intervention. 
Use of vascular age, if used globally, could be one of many tools used by a physician to develop good talking points and intervention for patients at risk.
Just my opinion.  
Connie

To unsubscribe or search other topics on UVM Flownet link to:
http://list.uvm.edu/archives/uvmflownet.html

ATOM RSS1 RSS2